Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

NCT05313620 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis
Thromboembolism

Interventions

DRUG: Tofacitinib
DRUG: Infliximab Adalimumab y Golimumab

Sponsor

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa